Prefilled Syringe Market is expected to reach US$ 15,003.68 million by 2030

Growing Demand for Adoption of Self-Injecting Parenteral Devices Drive Prefilled Syringe Market Growth 

According to our new research study on "Prefilled Syringe Market Forecast to 2030 – Global Analysis – by Type, Material, Product Type, Application, and End user," the market was valued at US$ 6,698.94 million in 2022 and is projected to reach US$ 15,003.68 million by 2030; it is estimated to register a CAGR of 10.6% from 2022 to 2030.

Self-injecting parenteral devices are gaining popularity due to the ease of use and ability to improve patient outcomes. These devices are designed to allow patients to self-administer medications at home or on the go and do not require assistance from healthcare professionals. These self-injection devices can help patients manage their symptoms more effectively and improve their quality of life. Moreover, self-injecting devices offer several advantages over traditional injection methods, such as the reduced risk of needlestick injuries, improved medication adherence, and reduction in overall healthcare costs. They also provide patients with greater control over their treatment, enabling them to adjust dosages and timing according to their individual needs.

Prefilled Syringe Market, by Type – 2022 and 2030

Further, pharmaceutical companies are increasingly investing in the development of self-injecting parenteral devices for prefilled syringes, and healthcare providers are encouraging their use as a part of a broader shift toward patient-centered care. With the ongoing advancements in technology and design, self-injecting devices will likely continue to gain popularity in the coming years. 

The prefilled syringe market is segmented as follows:

The prefilled syringe market is segmented on the basis of type, material, product type, application, distribution channel, and geography.

The prefilled syringe market, by type, is bifurcated into disposable prefilled syringes and reusable prefilled syringes. In 2022, the disposable prefilled syringes segment held a larger market share and is estimated to register a faster CAGR during 2022–2030.

Prefilled disposable syringes are designed to be used once, after which they are discarded to reduce the risk of contamination and infections. These syringes are used in healthcare settings for the administration of medications, vaccines, and other injectables. They can also be used in home healthcare settings for the self-administration of injectables at regular intervals. Prefilled disposable syringes are available in different types, such as insulin syringes, allergy syringes, and tuberculin syringes, with varying sizes. Moreover, the increased use of prefilled autoinjectors has generated the demand for disposable prefilled syringes as they are sold as a single dose. Moreover, increasing cases of allergies and infections among large populations, coupled with stringent safety guidelines from health ministries and other regulatory bodies worldwide, is expected to fuel the growth of disposable prefilled syringes.

Region Analysis – Prefilled Syringe Market

Based on geography, the prefilled syringe market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the prefilled syringe market. Asia Pacific is expected to register the highest CAGR in the global prefilled syringe market during 2022–2030.

The Asia Pacific prefilled syringe market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2022, and India is expected to have a significant growth rate in the market during the forecast period. The market growth in these countries is attributed to the advancements in the treatment of diabetes that have resulted in rising injectable therapies. Moreover, the Chinese Diabetes Society has taken a lead in insulin injection education over the past decade for the treatment of diabetes. Therefore, with high awareness and usability of prefilled syringes intended for diabetes population in China, the market for prefilled syringes will subsequently grow in the near future.  

The prevalence of diabetes is a standalone factor responsible for the prefilled syringes market growth in China. According to the Public Library of Science (PLoS) report 2022, about 12% of the adult population in China carries diabetes, which represents a 10-fold increase in the last 3–4 decades. The rising number of people with diabetes in China involves a complex interplay of socio-economic, demographic, environmental, and genetic factors. Additionally, major contributors include urbanization and aging population, as well as decreasing physical activity, leading to a decrease in weight and obesity.

Additionally, China still uses the 8-mm needle for its consumption of insulin. Needle reuse is a common practice in China, accounting for 78%. The availability of prefilled insulin syringes will also eliminate the chances of reuse, which further reduces the infection rate. Therefore, all the above factors are expected to drive the prefilled syringes market growth during the forecast period.

Gerresheimer AG, Schott Group, Nipro Medical Corporation, BD, Baxter International Inc., Terumo, YPSOMED, Weigao group, B Barun, and Deltamed are among the leading companies operating in the prefilled syringe market.     

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com